Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 9 |
GO:0042995 | cell projection | 2 | 9 |
GO:0043226 | organelle | 2 | 9 |
GO:0043227 | membrane-bounded organelle | 3 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 9 |
Related structures:
AlphaFold database: A4IAB4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 52 | 56 | PF00656 | 0.406 |
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.403 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.328 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.525 |
CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.328 |
CLV_PCSK_PC7_1 | 12 | 18 | PF00082 | 0.508 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.516 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.473 |
DOC_CYCLIN_RxL_1 | 114 | 124 | PF00134 | 0.427 |
DOC_CYCLIN_RxL_1 | 9 | 18 | PF00134 | 0.521 |
DOC_MAPK_MEF2A_6 | 128 | 136 | PF00069 | 0.310 |
DOC_PP1_RVXF_1 | 115 | 122 | PF00149 | 0.415 |
DOC_PP1_RVXF_1 | 126 | 132 | PF00149 | 0.294 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.455 |
DOC_USP7_MATH_1 | 233 | 237 | PF00917 | 0.671 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 65 | 69 | PF00917 | 0.529 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.407 |
DOC_WW_Pin1_4 | 227 | 232 | PF00397 | 0.524 |
DOC_WW_Pin1_4 | 35 | 40 | PF00397 | 0.435 |
LIG_14-3-3_CanoR_1 | 16 | 26 | PF00244 | 0.492 |
LIG_14-3-3_CanoR_1 | 192 | 198 | PF00244 | 0.460 |
LIG_14-3-3_CanoR_1 | 66 | 70 | PF00244 | 0.566 |
LIG_14-3-3_CanoR_1 | 96 | 101 | PF00244 | 0.438 |
LIG_Actin_WH2_2 | 38 | 56 | PF00022 | 0.343 |
LIG_BRCT_BRCA1_1 | 19 | 23 | PF00533 | 0.426 |
LIG_CSL_BTD_1 | 130 | 133 | PF09270 | 0.364 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.431 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.590 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.625 |
LIG_FHA_2 | 135 | 141 | PF00498 | 0.409 |
LIG_GBD_Chelix_1 | 158 | 166 | PF00786 | 0.391 |
LIG_LIR_Gen_1 | 40 | 51 | PF02991 | 0.416 |
LIG_LIR_Gen_1 | 73 | 81 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 20 | 26 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 40 | 46 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 73 | 78 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 87 | 93 | PF02991 | 0.331 |
LIG_NRBOX | 157 | 163 | PF00104 | 0.309 |
LIG_Pex14_1 | 131 | 135 | PF04695 | 0.359 |
LIG_SH2_CRK | 43 | 47 | PF00017 | 0.368 |
LIG_SH2_CRK | 97 | 101 | PF00017 | 0.348 |
LIG_SH2_NCK_1 | 97 | 101 | PF00017 | 0.348 |
LIG_SH2_PTP2 | 50 | 53 | PF00017 | 0.390 |
LIG_SH2_STAP1 | 43 | 47 | PF00017 | 0.412 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.356 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.388 |
LIG_SH3_3 | 36 | 42 | PF00018 | 0.470 |
LIG_SUMO_SIM_anti_2 | 155 | 163 | PF11976 | 0.408 |
LIG_SUMO_SIM_par_1 | 23 | 29 | PF11976 | 0.511 |
LIG_TRAF2_1 | 2 | 5 | PF00917 | 0.679 |
LIG_TYR_ITIM | 41 | 46 | PF00017 | 0.420 |
LIG_UBA3_1 | 190 | 195 | PF00899 | 0.336 |
MOD_CK1_1 | 148 | 154 | PF00069 | 0.309 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.407 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.447 |
MOD_GlcNHglycan | 176 | 180 | PF01048 | 0.398 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.328 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.554 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.396 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.400 |
MOD_GSK3_1 | 229 | 236 | PF00069 | 0.602 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.503 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.396 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.490 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.255 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.490 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.234 |
MOD_PIKK_1 | 148 | 154 | PF00454 | 0.324 |
MOD_PIKK_1 | 198 | 204 | PF00454 | 0.408 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.488 |
MOD_PKA_2 | 65 | 71 | PF00069 | 0.556 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.410 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.493 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.402 |
MOD_ProDKin_1 | 227 | 233 | PF00069 | 0.531 |
MOD_ProDKin_1 | 35 | 41 | PF00069 | 0.418 |
TRG_DiLeu_BaLyEn_6 | 21 | 26 | PF01217 | 0.521 |
TRG_DiLeu_BaLyEn_6 | 9 | 14 | PF01217 | 0.514 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.385 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.394 |
TRG_ER_diArg_1 | 15 | 17 | PF00400 | 0.532 |
TRG_ER_diArg_1 | 216 | 218 | PF00400 | 0.378 |
TRG_ER_diArg_1 | 47 | 49 | PF00400 | 0.385 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P9Z0 | Trypanosomatidae | 31% | 100% |
A0A3S7X8B4 | Leishmania donovani | 100% | 100% |
A4HB66 | Leishmania braziliensis | 75% | 100% |
C9ZLY2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9B5D7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q2J6 | Leishmania major | 92% | 100% |
V5BQJ6 | Trypanosoma cruzi | 32% | 100% |